SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
This Quarter Return
+9.18%
1 Year Return
+29.51%
3 Year Return
+13.62%
5 Year Return
+117.76%
10 Year Return
+239.6%
AUM
$605M
AUM Growth
+$605M
(+26%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
16.7%
Top 10 Holdings %
Top 10 Hldgs %
10.86%
Holding
696
New
282
Increased
102
Reduced
88
Closed
224
Top Buys
| 1 |
AbbVie
ABBV
|
$6.52M |
| 2 |
Incyte
INCY
|
$6.31M |
| 3 |
Teradyne
TER
|
$6.12M |
| 4 |
Delta Air Lines
DAL
|
$5.71M |
| 5 |
ResMed
RMD
|
$5.67M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$46.8M |
| 2 |
Carvana
CVNA
|
$8.46M |
| 3 |
Wynn Resorts
WYNN
|
$5.62M |
| 4 |
Apple
AAPL
|
$5.53M |
| 5 |
Novartis
NVS
|
$5.28M |
Sector Composition
| 1 | Technology | 21.71% |
| 2 | Consumer Discretionary | 17.11% |
| 3 | Healthcare | 15.75% |
| 4 | Industrials | 11.14% |
| 5 | Financials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Mueller Industries
MLI
$10.6B
| $674K | 0.11% |
+7,724
| New | +$674K |
|
252
Synopsys
SNPS
$110B
| $673K | 0.11% |
1,546
-10,237
| -87% | -$4.46M |
|
253
Ovintiv
OVV
$11B
| $666K | 0.11% |
+17,481
| New | +$666K |
|
254
Check Point Software Technologies
CHKP
$20.4B
| $662K | 0.11% |
+5,266
| New | +$662K |
|
255
Iridium Communications
IRDM
$2.63B
| $661K | 0.11% |
+10,639
| New | +$661K |
|
256
WEC Energy
WEC
$34.1B
| $657K | 0.11% |
+7,440
| New | +$657K |
|
257
Masco
MAS
$15.2B
| $656K | 0.11% |
+11,437
| New | +$656K |
|
258
AES
AES
$9.55B
| $646K | 0.11% |
31,174
+10,798
| +53% | +$224K |
|
259
Brown & Brown
BRO
$31.5B
| $637K | 0.11% |
9,251
-4,774
| -34% | -$329K |
|
260
Ultragenyx Pharmaceutical
RARE
$3.09B
| $637K | 0.11% |
+13,804
| New | +$637K |
|
261
Aflac
AFL
$56.5B
| $636K | 0.11% |
+9,110
| New | +$636K |
|
262
Foot Locker
FL
$2.3B
| $633K | 0.1% |
+23,351
| New | +$633K |
|
263
Allegion
ALLE
$14.4B
| $633K | 0.1% |
+5,274
| New | +$633K |
|
264
Tecnoglass
TGLS
$3.33B
| $632K | 0.1% |
+12,243
| New | +$632K |
|
265
AstraZeneca
AZN
$249B
| $632K | 0.1% |
8,825
-41,855
| -83% | -$3M |
|
266
Fortive
FTV
$16B
| $632K | 0.1% |
8,447
-8,376
| -50% | -$626K |
|
267
Fluor
FLR
$6.75B
| $620K | 0.1% |
+20,961
| New | +$620K |
|
268
Brown-Forman Class B
BF.B
$13.8B
| $620K | 0.1% |
+9,277
| New | +$620K |
|
269
Sysco
SYY
$38.5B
| $618K | 0.1% |
+8,330
| New | +$618K |
|
270
Manhattan Associates
MANH
$12.7B
| $612K | 0.1% |
+3,061
| New | +$612K |
|
271
D.R. Horton
DHI
$50.8B
| $611K | 0.1% |
5,024
+2,253
| +81% | +$274K |
|
272
APA Corp
APA
$8.53B
| $609K | 0.1% |
17,824
+10,756
| +152% | +$368K |
|
273
Neurocrine Biosciences
NBIX
$14.1B
| $606K | 0.1% |
+6,430
| New | +$606K |
|
274
General Dynamics
GD
$87.3B
| $606K | 0.1% |
2,815
-157
| -5% | -$33.8K |
|
275
Cushman & Wakefield
CWK
$3.57B
| $601K | 0.1% |
+73,412
| New | +$601K |
|